pharmaphorum
SEPTEMBER 16, 2020
Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. ACTT-2 used a 4mg dose of the drug, which wasn’t approved by the FDA on safety grounds.
The Pharma Data
JANUARY 15, 2021
15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. 13 in the New England Journal of Medicine , involved patients with high blood pressure in the lungs caused by interstitial lung disease (ILD). FRIDAY, Jan.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 10, 2022
After all, the EU Beating Cancer Plan was initiated before the pandemic and the tools that exist now – precision medicine, high-performance computing, AI – all of these are essentials for equitable access and innovative medicine. And in the UK over 30% of clinical trials funded has one European partner at least.
Drug Discovery World
SEPTEMBER 13, 2023
Integrated drug formulation and clinical trials company, BDD Clinical Trials, has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.
Expert insights. Personalized for you.
110 
Let's personalize your content